Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2018 | Pages:
103 | Publisher: Grand View Research
Industry: Textiles | Report Format: Electronic (PDF)
The North America Respiratory Protective Equipment (RPE) market size is expected to reach USD 2.86 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.9% over the forecast period. The industry is anticipated to witness growth owing to the stringent regulations and guidelines for employee safety, by various regulatory bodies such as Occupational Safety and Health Administration (OSHA) and Centers for Disease Control and Prevention (CDC). Increasing incidence of occupational illness and deaths in industries coupled with rapid outbreak of diseases urge various health regulatory bodies to adopt necessary measures for preventing further occurrences. The penetration of RPE for protecting employees against vapors, inhaling hazardous gases, chemical agents, particulates, radiological particles, and biological contaminants is projected to drive the product demand. Growing importance of raw materials offering features, such as lightweight, comfort, higher heat resistance, and low breathing resistance has been a significant incentive for companies to conduct extensive R&D. These initiatives are primarily aimed at achieving the multi-functionality of protective clothing by adding innovative add-ons to the existing equipment. Technological advancements and growing concerns about employee health and safety are anticipated to provide lucrative opportunities to market participants over the next few years. Product innovation for enhancing the shelf-life of respiratory protective equipment is further estimated to positively drive the North America Respiratory Protective Equipment (RPE) market over the projected period. Further key findings from the report suggest: • Air-purified Respirators (APR) accounted for 61.4% of market share in terms of revenue in 2017 owing to growing demand for powered, unpowered, and escape respirators in U.S. and Canada • In Mexico, demand for escape respirators is expected to be USD 12.2 million by 2026 as these masks are increasingly being used for protection against Chemical, Biological, Radiological, and Nuclear (CBRN) warfare agents • In Canada, demand for airline respirators is expected to witness significant CAGR of 7.1% during the forecast period as they provide respiratory protection for longer durations which aids its application in industrial applications • APR in the fire services industry in Mexico is expected to expand at a CAGR of 8.7% over the forecast period as APRs offer protection to the firefighters from different toxic and carcinogenic compounds • Major companies involved in the North America Respiratory Protective Equipment (RPE) market include 3M, DuPont, Avon Rubber plc, Alpha Pro-Tech, Ansell, Bullard, VF Imagewear (Bulwark), Delta Plus, ILC Dover, and Kimberley Clark Corporation
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. North America Respiratory Protective Equipment (RPE): Market Variables, Trends, and Scope
3.1. Market segmentation & scope
3.2. Market size and growth prospects, 2014 - 2026
3.3. Value chain analysis
3.4. Respiratory protective equipment - Technology outlook
3.5. Regulatory framework
3.6. Market dynamics
3.6.1. Market driver analysis
3.6.1.1. Favorable occupational safety regulations
3.6.1.2. Emergence of infectious biological hazards
3.6.1.3. Rising incidence of mesothelioma disease
3.6.2. Market restraint analysis
3.6.2.1. Lack of awareness
3.6.2.2. Complex manufacturing methods
3.7. Key opportunities prioritized
3.8. Industry analysis - Porter's
3.9. PESTEL analysis
Chapter 4. North America Respiratory Protective Equipment (RPE) Market: Product Estimates & Trend Analysis
4.1. North America RPE market share, by product, 2017 & 2026
4.2. Air-purifying respirators (APR)
4.2.1. North America APR revenue estimates and forecasts, 2014 - 2026
4.2.2. Unpowered air-purifying respirators
4.2.2.1 Market estimates & forecasts, 2014 - 2026
4.2.2.2 Disposable filtering half mask respirator
4.2.2.2.1 Market estimates & forecasts, 2014 - 2026
4.2.2.3 Half mask respirator
4.2.2.3.1 Market estimates & forecasts, 2014 - 2026
4.2.2.4 Full face mask respirator
4.2.2.4.1 Market estimates & forecasts, 2014 - 2026
4.2.3. Powered air-purifying respirators (PAPR)
4.2.3.1 Market estimates & forecasts, 2014 - 2026
4.2.3.2 Half mask respirator
4.2.3.2.1 Market estimates & forecasts, 2014 - 2026
4.2.3.3 Full face mask respirator
4.2.3.3.1 Market estimates & forecasts, 2014 - 2026
4.2.3.4 Helmets, hoods, visors
4.2.3.4.1 Market estimates & forecasts, 2014 - 2026
4.2.4. Escape respirators
4.2.4.1 Market estimates & forecasts, 2014 - 2026
4.3. Supplied air respirators
4.3.1. Market estimates & forecasts, 2014 - 2026
4.3.2. Self-contained breathing apparatus (SCBA)
4.3.2.1 Market estimates & forecasts, 2014 - 2026
4.3.3. Full face mask
4.3.3.1 Market estimates & forecasts, 2014 - 2026
4.3.4. Airline respirators
4.3.4.1 Market estimates & forecasts, 2014 - 2026
Chapter 5. North America Respiratory Protective Equipment (RPE) Market: End-Use Estimates & Trend Analysis
5.1. North America RPE market share, by end-use, 2016 & 2026
5.2. Oil & gas
5.2.1. Revenue estimates and forecasts in oil & gas, 2014 - 2026
5.3. Fire services
5.3.1. Revenue estimates and forecasts in fire services, 2014 - 2026
5.4. Petrochemical/chemical
5.4.1. Revenue estimates and forecasts in petrochemical/chemical, 2014 - 2026
5.5. Industrial
5.5.1. Revenue estimates and forecasts in industrial, 2014 - 2026
5.6. Construction
5.6.1. Revenue estimates and forecasts in construction, 2014 - 2026
5.7. Pharmaceuticals
5.7.1. Revenue estimates and forecasts in pharmaceuticals, 2014 - 2026
5.8. Healthcare
5.8.1. Revenue estimates and forecasts in healthcare, 2014 - 2026
5.9. Mining
5.9.1. Revenue estimates and forecasts in mining, 2014 - 2026
5.10. Others
5.10.1. Revenue estimates and forecasts in other applications, 2014 - 2026
Chapter 6. North America Respiratory Protective Equipment (RPE) Market: Country Estimates & Trend Analysis
6.1. North America RPE market share, by country, 2016 & 2026
6.2. North America
6.2.1. Revenue estimates and forecasts, 2014 - 2026
6.2.2. Revenue estimates and forecasts, by product, 2014 - 2026
6.2.2.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.2.1.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.2.1.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.2.1.3 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.2.2 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.2.3 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.2.3.1 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.3. Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.4. U.S.
6.2.4.1 Revenue estimates and forecasts, 2014 - 2026
6.2.4.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.4.2.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.4.2.1.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.4.2.1.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.4.2.1.3 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.4.2.2 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.4.2.3 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.4.2.3.1 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.4.3 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.5. Canada
6.2.5.1 Revenue estimates and forecasts, 2014 - 2026
6.2.5.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.5.2.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.5.2.1.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.5.2.1.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.5.2.1.3 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.5.2.2 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.5.2.3 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.5.2.3.1 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.5.3 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.6. Mexico
6.2.6.1 Revenue estimates and forecasts, 2014 - 2026
6.2.6.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.6.2.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.6.2.1.1 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.6.2.1.2 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.6.2.1.3 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.6.2.2 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.6.2.3 Revenue estimates and forecasts, by product, 2014 - 2026
6.2.6.2.3.1 Revenue estimates and forecasts, by end-use, 2014 - 2026
6.2.6.3 Mexico RPE revenue estimates and forecasts, by end-use, 2014 - 2026
Chapter 7. Competitive Landscape
7.1. Vendor landscape
7.2. Competitive environment
7.3. Strategy framework
Chapter 8. Company Profiles
8.1. 3M Company
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Avon Rubber plc
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Alpha Pro Tech
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Ansell Ltd.
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Bullard
8.5.1. Company Overview
8.5.2. Product Benchmarking
8.5.3. Strategic Initiatives
8.6. VF Imagewear (Bulwark)
8.6.1. Company Overview
8.6.2. Product Benchmarking
8.6.3. Strategic Initiatives
8.7. Delta Plus
8.7.1. Company Overview
8.7.2. Product Benchmarking
8.7.3. Strategic Initiatives
8.8. ILC Dover
8.8.1. Company Overview
8.8.2. Product Benchmarking
8.8.3. Strategic Initiatives
8.9. DuPont
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Bio-Medical Devices International, Inc.
8.10.1. Company Overview
8.10.2. Product Benchmarking
8.10.3. Strategic Initiatives
8.11. Kimberly-Clark Corporation
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.12. Mine Safety Appliances Company (MSA)
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Scott Safety
8.13.1. Company Overview
8.13.2. Product Benchmarking
8.13.3. Strategic Initiatives
8.14. Honeywell International, Inc.
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives
8.15. Uvex Safety Group
8.15.1. Company Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Strategic Initiatives
List of Tables TABLE 1 North America respiratory protective equipment (RPE) market - Key market driver impact TABLE 2 Standard codes regarding safety and health in various work environments TABLE 3 Respiratory Protective Equipment - Key market restraint impact TABLE 4 North America APR revenue estimates and forecasts, 2014 - 2026 (USD Million) TABLE 5 North America unpowered air-purifying respirators market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 6 North America disposable filtering half mask respirator market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 7 North America half mask respirator market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 8 North America full face mask respirator market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 9 North America PAPR market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 10 North America half mask respirator market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 11 North America full face mask respirator market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 12 North America helmets, hoods, visors market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 13 North America escape respirators market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 14 North America supplied air respirators market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 15 North America SCBA market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 16 North America full face mask market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 17 North America airline respirators market estimates & forecasts, 2014 - 2026 (USD Million) TABLE 18 North America RPE revenue estimates and forecasts in oil & gas, 2014 - 2026 (USD Million) TABLE 19 North America RPE revenue estimates and forecasts in fire services, 2014 - 2026 (USD Million) TABLE 20 North America RPE revenue estimates and forecasts in petrochemical/chemical, 2014 - 2026 (USD Million) TABLE 21 North America RPE revenue estimates and forecasts in industrial, 2014 - 2026 (USD Million) TABLE 22 North America RPE revenue estimates and forecasts in construction, 2014 - 2026 (USD Million) TABLE 23 North America RPE revenue estimates and forecasts in pharmaceuticals, 2014 - 2026 (USD Million) TABLE 24 North America RPE revenue estimates and forecasts in healthcare, 2014 - 2026 (USD Million) TABLE 25 North America RPE revenue estimates and forecasts in mining, 2014 - 2026 (USD Million) TABLE 26 North America RPE revenue estimates and forecasts in other applications, 2014 - 2026 (USD Million) TABLE 27 North America RPE revenue estimates and forecasts, 2014 - 2026 (USD Million) TABLE 28 North America RPE revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 29 North America air-purifying respirators (APR) revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 30 North America unpowered APR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 31 North America PAPR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 32 North America PAPR revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 33 North America air-purifying respirators (APR) revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 34 North America supplied air respirators revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 35 North America SCBA revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 36 North America RPE revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 37 U.S. RPE revenue estimates and forecasts, 2014 - 2026 (USD Million) TABLE 38 U.S. RPE revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 39 U.S. air-purifying respirators (APR) revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 40 U.S. unpowered APR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 41 U.S. PAPR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 42 U.S. PAPR revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 43 U.S. air-purifying respirators (APR) revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 44 U.S. supplied air respirators revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 45 U.S. SCBA revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 46 U.S. RPE revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 47 Canada RPE revenue estimates and forecasts, 2014 - 2026 (USD Million) TABLE 48 Canada RPE revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 49 Canada air-purifying respirators (APR) revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 50 Canada unpowered APR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 51 Canada PAPR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 52 Canada PAPR revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 53 Canada air-purifying respirators (APR) revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 54 Canada supplied air respirators revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 55 Canada SCBA revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 56 Canada RPE revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 57 Mexico RPE revenue estimates and forecasts, 2014 - 2026 (USD Million) TABLE 58 Mexico RPE revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 59 Mexico air-purifying respirators (APR) revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 60 Mexico unpowered APR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 61 Mexico PAPR revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 62 Mexico PAPR revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 63 Mexico air-purifying respirators (APR) revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 64 Mexico supplied air respirators revenue estimates and forecasts, by product, 2014 - 2026 (USD Million) TABLE 65 Mexico SCBA revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million) TABLE 66 Mexico RPE revenue estimates and forecasts, by end-use, 2014 - 2026 (USD Million)
List of Figures FIG. 1 North America respiratory protective equipment (RPE) market segmentation FIG. 2 North America respiratory protective equipment market, by revenue, 2014 - 2026 (USD Million) FIG. 3 North America respiratory protective equipment (RPE) market - Value chain analysis FIG. 4 North America respiratory protective equipment (RPE) market dynamics FIG. 5 Top five countries for mesothelioma clinical trials, in 2015 FIG. 6 Key opportunities prioritized FIG. 7 North America respiratory protective equipment (RPE) market- Porter's analysis FIG. 8 North America respiratory protective equipment (RPE) market - PESTEL analysis FIG. 9 North America RPE market revenue share, by product, 2016 & 2026 FIG. 10 North America RPE market revenue share, by end-use, 2016 & 2026 FIG. 11 North America RPE market revenue share, by country, 2016 & 2026 FIG. 12 Competitive strategy adopted by leading players
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
